000 01425 a2200409 4500
005 20250513205019.0
264 0 _c20000613
008 200006s 0 0 eng d
022 _a0960-894X
024 7 _a10.1016/s0960-894x(00)00062-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCoates, P A
245 0 0 _aProbes for imidazoline binding sites: synthesis and evaluation of a selective, irreversible I2 ligand.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cMar 2000
300 _a605-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBinding, Competitive
_xdrug effects
650 0 4 _aBrain Chemistry
_xdrug effects
650 0 4 _aImidazoline Receptors
650 0 4 _aIn Vitro Techniques
650 0 4 _aKidney
_xdrug effects
650 0 4 _aLigands
650 0 4 _aPhotoaffinity Labels
650 0 4 _aRats
650 0 4 _aReceptors, Adrenergic, alpha-2
_xdrug effects
650 0 4 _aReceptors, Drug
_xdrug effects
700 1 _aGrundt, P
700 1 _aRobinson, E S
700 1 _aNutt, D J
700 1 _aTyacke, R
700 1 _aHudson, A L
700 1 _aLewis, J W
700 1 _aHusbands, S M
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 10
_gno. 6
_gp. 605-7
856 4 0 _uhttps://doi.org/10.1016/s0960-894x(00)00062-7
_zAvailable from publisher's website
999 _c10694997
_d10694997